NCT01736644
Completed
N/A
A Prospective Randomized Control Trial to Compare the Aquamantys System With Standard Electrocautery in Reducing Blood Loss in Primary Total Knee Arthroplasty
Medtronic Surgical Technologies2 sites in 1 country97 target enrollmentOctober 2012
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Osteoarthritis
- Sponsor
- Medtronic Surgical Technologies
- Enrollment
- 97
- Locations
- 2
- Primary Endpoint
- Blood Loss
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
This study will compare the clinical outcomes for patients undergoing a total knee replacement using a bipolar sealer, the Aquamantys® System, as compared to standard electrocautery. Total blood loss during the hospital stay and knee mobility and discharge factors will be analyzed.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient is ≥18 years of age
- •Patient has failed conservative therapy of osteoarthritis of the knee and has been listed to undergo primary TKA
- •Patient is willing and able to provide written informed consent.
- •Pre-assessment Haemoglobin ≥ 11.0g/dl
- •Patient is suitable to receive spinal anaesthesia with no peripheral nerve blocks
- •Patients willing to undergo blood transfusion
Exclusion Criteria
- •Patients that are listed for unicondylar or revision TKA
- •Patients who are being converted from a previous high tibial osteotomy and a previous unicondylar knee arthroplasty
- •Fixed motor deficit thus affecting functional assessment of the knee
- •Patients presenting with a non-osteoarthritis degenerative knee diagnosis
- •Patients presenting with known contralateral knee osteoarthritis requiring simultaneous bilateral TKA
- •Patients presenting with a history of previous knee infection
- •Patients presenting with a pre-operative knee range of motion \< 85°
- •Knee deformity greater than 20 degrees varus or valgus
- •Patients presenting with a history of bleeding disorders and/or are on chronic blood anticoagulation therapy
- •Patients with significantly impaired renal function (defined by EGFR \>30)
Outcomes
Primary Outcomes
Blood Loss
Time Frame: upto to 72 hrs after surgery
The primary outcome will be total blood loss throughout the hospital stay.
Secondary Outcomes
- Rehabilitation(6-weeks)
Study Sites (2)
Loading locations...
Similar Trials
Unknown
N/A
Comparison of Three Knee ReplacementsOsteoarthritis, KneeArthroplastyTotal Knee ReplacementNCT03339557Coxa, Hospital for Joint Replacement240
Completed
N/A
Study Comparing BoneMaster Hydroxyapatite Coating With Plasma-sprayed Hydroxyapatite Coating on Acetabular CupsArthropathy of HipNCT00859976Zimmer Biomet167
Completed
N/A
Prospective Double-blinded Randomised Comparison of Profix Mobile to Fixed Bearing Knee ReplacementsOsteoarthritisNCT02157220The University of New South Wales77
Unknown
N/A
Randomised Controlled Trial PFC Versus CKS Total Knee ProsthesesOsteoarthritis, KneeNCT00228137Radboud University Medical Center90
Completed
N/A
Study to Evaluate ACB Versus FNB Early Postoperative Period Functional Outcomes After TKAArthroplasty, Replacement, KneeNerve BlockNCT02218814George Macrinici106